InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by FOUSE JACQUALYN A, Chairman & CEO. Insider active across 2 companies, notably INCYTE CORP. Cumulatively, 13 reports have been published. The latest transaction was disclosed on 30 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
€19,939275 shares@ €72.50650.0001% mcap13.9% of flow
Common Stock
SEC:0001209191-22-040182:0·
02,144 shares0
Common Stock
SEC:0001209191-22-037800:0·
€20,084280 shares@ €71.72820.0001% mcap14.0% of flow
Common Stock
SEC:0001209191-22-022293:0·
012,379 shares0
Common stock
SEC:0001439222-22-000017:0·
011,334 shares0
Common stock
SEC:0001439222-22-000012:0·
€18,731289 shares@ €64.81220.0001% mcap36.2% of flow
Common Stock
SEC:0001209191-22-000702·
€18,731289 shares@ €64.81220.0001% mcap13.1% of flow
Common Stock
SEC:0001209191-22-000702:0·
€16,104271 shares@ €59.42390.0001% mcap31.1% of flow
Common Stock
SEC:0001209191-21-058982·
€16,104271 shares@ €59.42390.0001% mcap11.2% of flow
Common Stock
SEC:0001209191-21-058982:0·
€16,887238 shares@ €70.95520.0001% mcap32.7% of flow
Common Stock
SEC:0001209191-21-044644·
€16,887238 shares@ €70.95520.0001% mcap11.8% of flow
Common Stock
SEC:0001209191-21-044644:0·
01,923 shares0
Common Stock
SEC:0001209191-21-036405·
01,923 shares0
Common Stock
SEC:0001209191-21-036405:0·
13 of 13 declarations
About FOUSE JACQUALYN A
FOUSE JACQUALYN A serves as Chief Executive Officer of Incyte Corp and Agios Pharmaceuticals, Inc. In this role, she is responsible for the strategic direction of the companies, managing operations, and overseeing financial performance. Her leadership is essential in ensuring the growth and sustainability of the companies in a competitive environment.
